Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$277.7K
56.67K shares
What this filing means
FAIRLEY RICKI LOUISE plans to sell 56.67K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $277.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/9/2025ACC: 0001972362-25-000422
Director
Since Mar 2023
56.67K
Shares to sell
$277.7K
Approx. market value
56.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
RESTRICTED STOCK
NOT APPLICABLE
3/27/2025
28.33KRESTRICTED STOCK
NOT APPLICABLE
3/27/2024
28.33KTotal acquired56.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2025 | RESTRICTED STOCK NOT APPLICABLE | 28.33K | — |
3/27/2024 | RESTRICTED STOCK NOT APPLICABLE | 28.33K | — |
| Total | 56.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
56.67K
Market value
$277.7K
5/9/2025
Total
Units
56.67K
Value
$277.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/9/2025 | 56.67K | $277.7K | NASDAQ | Planned |
| Total | 56.67K | $277.7K | ||